IL-10 Gene Polymorphism in Iraqi Lymphoblastic Leukemia Patients in Relation to EBV Infection

The Epstein-Barr virus (EBV) is an oncogenic virus that persists in a latent state within B-lymphocyte cells. This virus has been associated with numerous forms of haematologic malignancies, including leukaemia. The focus has been on the association between single nucleotide polymorphisms (SNPs), such as those in Interleukin-10, and leukaemia patients. The enzyme-linked immunosorbent assay (ELISA) was employed to identify Epstein-Barr virus EBNA-1-IgG, whereas the Sanger sequencing approach was utilised to detect Interleukin-10 SNPs. This study aimed to ascertain the presence of Epstein-Barr virus EBNA-1-IgG in patients with acute lymphocytic leukaemia and to investigate Interleukin-10 single nucleotide polymorphisms (SNPs) -819T˃C (rs1800871) and -592A˃C (rs1800872) in patients with acute lymphoblastic leukaemia. The statistical examination of the immunological assay indicated no significant difference between the proportion of patients positive for EBV EBNA-1-IgG and the positive controls. The statistical analysis reveals a substantial disparity in the proportion of CC genotype carriers at IL10 -819T˃C (rs1800871) between patients and controls within the molecular study framework. A notable difference was seen in the prevalence of TC genotype carriers at IL10 -819T˃C (rs1800871) between patients and controls. A significant difference was observed between healthy controls and patients with AC, AA, and CC genotype carriers at IL10 -592A>C (rs1800872). This study illustrates the notable prevalence of Epstein-Barr virus (EBV) in individuals with acute lymphoblastic leukaemia. This study demonstrates the association between acute lymphoblastic leukaemia and the CC and TC genotypes at IL10-819T˃C (rs1800871), along with the AC, CC, and AA genotypes at IL10 -592A˃C (rs1800872).